MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
MeSH term | MeSH ID | Detail |
---|---|---|
Otitis Media | D010033 | 12 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Whooping Cough | D014917 | 6 associated lipids |
Fecal Impaction | D005244 | 1 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Drew R and Piestly BG | Effect of chlorpromazine and erythromycin on bile salt-induced cholestasis in the rat. | 1979 | Pharmacology | pmid:572556 |
Dujovne CA and Salhab AS | Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems. | 1980 | Pharmacology | pmid:7403251 |
Ramin U and Wollmann H | [Problems in the determination of water content of lubomycin B capsules]. | 1990 | Pharmazie | pmid:2080216 |
Potthast H et al. | [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state]. | 1995 | Pharmazie | pmid:7886126 |
Henry J et al. | Plasma and salivary concentrations of erythromycin after administration of three different formulations. | 1980 | Postgrad Med J | pmid:7220406 |
Garnham JC | Trade names or approved names. Part III. Special cases. Clinical trials. | 1974 | Postgrad Med J | pmid:4465771 |
Lai CC et al. | Analysis of a commercial preparation of erythromycin estolates by tandem mass spectrometry and high performance liquid chromatography/electrospray ionization tandem mass spectrometry using an ion trap mass spectrometer. | 2000 | Rapid Commun. Mass Spectrom. | pmid:10717658 |
Hillyer D | Is erythromycin indicated in pregnancy? | 1992 | RN | pmid:1594870 |
Pari L and Uma A | Protective effect of Sesbania grandiflora against erythromycin estolate-induced hepatotoxicity. | 2003 Sep-Oct | Therapie | pmid:14682193 |
Gaeta GB et al. | Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver. | 1985 | Toxicol. Appl. Pharmacol. | pmid:2992120 |
Sorensen EM and Acosta D | Erythromycin estolate-induced toxicity in cultured rat hepatocytes. | 1985 | Toxicol. Lett. | pmid:4060187 |
Morgan RE et al. | A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. | 2013 | Toxicol. Sci. | pmid:23956101 |
Morgan RE et al. | Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. | 2010 | Toxicol. Sci. | pmid:20829430 |
de Longueville F et al. | Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. | 2003 | Toxicol. Sci. | pmid:12883083 |
Zidek N et al. | Acute hepatotoxicity: a predictive model based on focused illumina microarrays. | 2007 | Toxicol. Sci. | pmid:17522070 |
Villa P et al. | Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. | 1992 | Toxicology | pmid:1609428 |
Davila JC et al. | Protective effect of flavonoids on drug-induced hepatotoxicity in vitro. | 1989 | Toxicology | pmid:2756528 |
Villa P et al. | Erythromycin toxicity in primary cultures of rat hepatocytes. | 1985 Aug-Sep | Xenobiotica | pmid:4072263 |